Scholl Seal and Heal verruca removal gel

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Racemic camphor; Salicylic acid

Available from:

Scholl's Wellness Company Ltd

INN (International Name):

Racemic camphor; Salicylic acid

Dosage:

31.1mg/1gram ; 125mg/1gram

Pharmaceutical form:

Cutaneous solution

Administration route:

Cutaneous

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 13070000; GTIN: 5052197021288

Summary of Product characteristics

OBJECT 1
SCHOLL SEAL AND HEAL VERRUCA
REMOVAL GEL
Summary of Product Characteristics Updated 24-Jan-2017 | Reckitt
Benckiser Healthcare (UK) Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Scholl Corn and Callous Removal Liquid
Scholl Medicated Corn and Callous Removal Liquid
Seal and Heal Verruca Removal Gel
2. Qualitative and quantitative composition
INGREDIENT
% W/W
Salicylic Acid EP
12.50
Camphor BP
3.11
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Topical solution
4. Clinical particulars
4.1 Therapeutic indications
For the treatment of corns, calluses, common warts and plantar warts
(verrucas).
4.2 Posology and method of administration
POSOLOGY
Treatment may be continued for up to twelve weeks except on medical
advice.
Adults:
Apply directly to the callus, corn, verruca or wart twice a day.
Paediatric Population
Children over 12 years:
As above for adults.
Children aged under 12 years of age:
Not recommended for children under twelve.
M